ArticleBMJ (Clinical research ed.)2024

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.

Björn Pasternak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.